Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the long-term safety, tolerability, and efficacy of Balinatunfib in participants with Crohn's disease or ulcerative colitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Balinatunfib

Snippet

Sponsor: Sanofi | Conditions: Colitis Ulcerative, Crohn's Disease | Phase 2 | Status: NOT_YET_RECRUITING